
Please try another search
For the fiscal year ended 31 December 2021, Jasper Therapeutics Inc revenues was not reported. Net loss increased from $6.5M to $30.6M. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.52 to -$2.69.
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -12.08 | -10.08 | -14.67 | -0.21 |
Net Income | -9.06 | -3.41 | -18.17 | 5.5 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 93.65 | 107.21 | 100.55 | 100.96 |
Total Liabilities | 24.14 | 28.61 | 14.26 | 11.1 |
Total Equity | 69.52 | 78.6 | 86.29 | 89.86 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -33.68 | -19.09 | -0.68 | -0.32 |
Cash From Investing Activities | -2.43 | -1.72 | 0.22 | 0.14 |
Cash From Financing Activities | 100.97 | 101.88 | ||
Net Change in Cash | 64.86 | 81.07 | -0.46 | -0.18 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review